Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy
NCT04778579
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Acute Lymphoid Leukemia
Interventions
DRUG:
ARI-0001 cells
Sponsor
Sara V. Latorre
Collaborators
[object Object]
[object Object]